Axel Schörling
Fortune : 1 M $ au 31/05/2026
Fortune : 1 M $ au 31/05/2026
Axel Schörling is President & Chief Executive Officer at EQL Pharma AB since 2022 and Independent Director at Gasporox AB since 2023.
Formerly, Mr. Schörling was Director-Business Controlling at Perstorp AB. Mr. Schörling graduated from Chalmers University of Technology and Handelshögskolan i Göteborg.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EQL PHARMA AB 1,36 % | 27/03/2026 | 401 445 ( 1,36 % ) | 1 M $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| EQL PHARMA AB | Directeur Général | 17/08/2022 |
| GASPOROX AB | Directeur/Membre du Conseil | 01/01/2023 |
| Sociétés | Poste | Fin |
|---|---|---|
| PERSTORP HOLDING AB (PUBL.) | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Perstorp AB
Perstorp AB Chemicals: SpecialtyProcess Industries Manufactures and supplies specialty chemicals | Process Industries |
Chalmers University of Technology
Chalmers University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gasporox AB
Gasporox AB Miscellaneous Commercial ServicesCommercial Services Provides laser technology and aims to benefits from non-intrusive diode laser spectroscopy technology | Commercial Services |
Handelshögskolan i Göteborg
Handelshögskolan i Göteborg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EQL Pharma AB
EQL Pharma AB Pharmaceuticals: GenericHealth Technology Manufactures and distributes generic and specialty pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national